-
COVID-19’s Impact on Patients and Clinical Care, Other News
Jun 05 | Clinical Research News | Researchers around the globe are studying how COVID-19 impacts patients and clinical care. Findings include high percentages of asymptomatic patients, how pulmonary embolism in involved in the disease, new data on convalescent plasma, and many concerning updates about decreased cardiac care. More -
How Multifactor Authentication Helps Keep Patient Data Private During a Pandemic
Jun 03 | Clinical Research News Contributed Commentary | Whether you are a doctor or a patient, the last thing that’s likely on anyone’s mind during a pandemic is data privacy. But just because the economy and our social lives are pretty much on hold because of COVID-19, that doesn’t mean healthcare privacy can afford to be. More -
Researchers Continue Treating Patients Amid Pandemic, Other COVID-19 News
May 29 | Clinical Research News | This week saw the clinical research community make a concerted effort to continue treating patients amid the COVID-19 pandemic. And in the meantime, COVID-19 related research is still in progress. More -
Research Ethics Knocked Sideways By The Pandemic
May 28 | Clinical Research News | Researchers are accustomed to having their ideas held up to scientific scrutiny, and testing and building on each other’s work, because that’s what moves the field toward more accurate explanations for problems and probable solutions. But the academic banter has largely devolved into discourses at the extremes during the current pandemic. More -
NHS, Deep Lens, SDL, And More: News From May 2020
May 27 | Clinical Research News | May was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from NHS, Deep Lens, SDL, and more. More -
Study Finds Not Enough Women, Older Adults In Cholesterol Trials
May 26 | Clinical Research News Brief | After analyzing the trends in the types of 485,409 people enrolled in 60 studies from 1990 to 2018, Johns Hopkins Medicine researchers report that, although some progress has been made, women and older adults are still vastly underrepresented in lipid lowering therapy trials compared with their disease burden. More -
Trials Reveal New Understanding of COVID-19, And Other News
May 22 | Clinical Research News | Researchers have found that COVID-19 patients have a high predisposition to developing blood clots. Elsewhere, teams develop a COVID-19 trial finder. We round up the week’s research and industry news for COVID-19. More -
Insights From COVID-19 Studies, And Other News
May 15 | Clinical Research News | New evidence may explain why men are more vulnerable to COVID-19 than women. An association between low average levels of vitamin D and high numbers of COVID-19 cases, and more. We round up the week’s research and industry news for COVID-19. More -
FDA Guidance: Q+A on Clinical Trial Operations Amidst COVID-19
May 13 | Clinical Research News Contributed Commentary | The Food and Drug Administration, like everyone one in American society today, is having to adapt its oversight and enforcement of clinical studies to be more flexible while still protecting the safety and rights of study participants and staff. This is clearly harder than it sounds. More -
COVID-19 And Cancer: Global Snapshot of Patient Experiences
May 12 | Clinical Research News | Oncology specialists working in pandemic hot spots around the world shared their experiences in treating COVID-19 infection in patients with cancer at the virtually held 2020 annual meeting of the American Association for Cancer Research. More
The DIA 2020 Global Annual Meeting is more than a meeting: it's an experience focused on the future of health. Spanning the life sciences spectrum, DIA 2020 will compile more than 250 sessions over 13 unique tracks with nine various learning formats, ensuring each attendee has the best learning opportunities.
Patient-centric pharma - Advancing the new business model reveals how success can be achieved and provides food for thought on various ways to place patients firmly at the heart of your business and achieve commercially beneficial outcomes.
